Original language | English |
---|---|
Pages (from-to) | 551-552 |
Number of pages | 2 |
Journal | Cancer Chemotherapy and Pharmacology |
Volume | 71 |
Issue number | 2 |
DOIs |
|
State | Published - Feb 2013 |
Erratum: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation (Cancer Chemother Pharmacol (2013) 71 (43-51))
Yoon Koo Kang, Byung Woog Kang, Seock Ah Im, Jae Lyun Lee, Sook Ryun Park, Won Ki Kang, Heung Moon Chang, Tae Won Kim, Do Youn Oh, Kyung Hae Jung, Min Hee Ryu
Research output: Contribution to journal › Comment/debate